Sipuleucel-T (Provenge®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention
Keyword(s):
2008 ◽
Vol 78
(1)
◽
pp. 3-8
◽
Keyword(s):